Probiotics and the skin

Clinics in Dermatology

Volumn 26, Issue 1, 2008, Pages 4-11

  Caramia, Giuseppe ^a   Atzei, Alessandra ^b   Fanos, Vassilios ^b  

^a G Salesi Academic Hospital   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIALLERGIC AGENT; BETA INTERFERON; CHEMOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTOXIN; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPY; BACTEROIDES; BIFIDOBACTERIACEAE; EPITHELIUM CELL; HUMAN; IMMUNE SYSTEM; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; LITERATURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIN DISEASE; TH1 CELL; TH2 CELL;

BACTEREMIA; BIFIDOBACTERIUM; CHILD; CLINICAL TRIALS AS TOPIC; DERMATITIS; DERMATITIS, ATOPIC; HUMANS; INFANT, NEWBORN; INTESTINAL MUCOSA; LACTOBACILLUS; MILK HYPERSENSITIVITY; PROBIOTICS; SKIN;

EID: 38949118228     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2007.10.008     Document Type: Article

References (79)

1. Metchnikoff E. The prolongation of life (1907), Putman and Sons, New York 1-38
2. Lilly D.M., and Stillwell R.H. Probiotics: growth promoting factors produced by microorganisms. Science 147 (1965) 747-748
3. Grunlund M.M., Lehtonen O.P., Eerola E., et al. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after Caesarean delivery. J Pediatr Gastroenterol Nutr 28 (1999) 19-25
4. Mattila-Sandholm T., and Blum S. Probiotics: towards demonstrating efficacy. Trends Food Sci Technol 10 (1999) 393-399
5. Harmsen H.G., Wildeboer-Veloo A.C., Roangs G.C., et al. Analysis of intestinal flora development in breast-fed infant by using molecular identifications and detection methods. J Pediatr Gastroenterol Nutr 30 (2000) 61-67
6. Probert H.M., and Gibson G.R. Bacterial biofilms in the human gastrointestinal tract. Curr Issues Intest Microbiol 3 (2002) 23-27
7. Gebbers J.O., and Laissue J.A. Postnatal immunomorphology of the gut. In: Hadziselimovc F., Herzog B., and Burgin-Wolff A. (Eds). Inflammatory bowel disease and coeliac disease in children (1990), Academic Publishers, Dordrecht 3-44
8. Noverr M.C., and Huffnagle G.B. Does the microbiota regulate immune responses outside the gut?. Trends Microbiol 12 (2004) 562-568
9. Sepp E., Julge K., Vasar M., et al. Intestinal microflora of Estonian and Swedish infants. Acta Pediatr 86 (1997) 956-961
10. Blum S., Delneste Y., Donnet A., et al. The influence of probiotic organisms on the immune response. Nutr Immunol Princ Pract 1 (2000) 451-455
11. Perdigon G., Fuller R., and Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2 (2001) 27-42
12. Kramer M.S., Guo T., Platt R.W., et al. Does previous infection protect against atopic eczema and recurrent wheeze in infancy?. Clin Exp Allergy 34 (2004) 753-756
13. Benn C.S., Melbye M., Wohlfahrt J., et al. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 328 (2004) 223
14. Zutavern A., Hirsch T., Leupold W., et al. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy 35 (2005) 1301-1308
15. Rautava S., Ruuskanen O., Ouwehand A., et al. The hygiene hypothesis of atopic disease-an extended version. J Pediatr Gastroenterol Nutr 38 (2004) 378-388
16. Alm J.S., et al. An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr Allergy Immunol 3 (2002) 402-411
17. Schmidt W.P. Model of the epidemic of childhood atopy. Med Sci Monit 10 (2004) HY5-HY9
18. Flohr C., Pascoe D., and Williams H.C. Atopic dermatitis and the ehygiene hypothesisf: too clean to be true?. Br J Dermatol 152 (2005) 202-216
19. Halken S. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatr Allergy Immunol 4-5 15 Supp 16 (2004) 9-32
20. Noverr M.C., Noggle R.M., Toews G.B., et al. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun 72 (2004) 4996-5003
21. Noverr M.C., Falkowski N., McDonald R.A., et al. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun 73 (2005) 30-38
22. Macpherson A.J., and Harris N.L. Opinion: interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4 (2004) 478-485
23. Xu J., Chiang H.C., Bjursell M.K., et al. Message from a human gut symbiont: sensitivity is a prerequisite for sharing. Trends Microbiol 12 (2004) 21-28
24. Hooper L.V. Bacterial contributions to mammalian gut development. Trends Microbiol 12 (2004) 129-134
25. Renz H., Blumer N., Virna S., et al. The immunological basis of the hygiene hypothesis. Chem Immunol Allergy 91 (2006) 30-48
26. Floistrup H., Swartz J., Bergstrom A., et al. Allergic disease and sensitization in Steiner school children. The Parsifal Study Group. J Allergy Clin Immunol 117 (2006) 59-66
27. Zutavern A., Brockow I., Schaaf B., et al. Timing of solid food introduction in relation to atopic dermatitis and atopic sensitization: results from a prospective birth cohort study. LISA Study Group. Pediatrics 117 (2006) 401-411
28. Russo M., Nahori M.A., Lefort J., et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol 24 (2001) 518-526
29. Chung Y., Cho J., Chang Y.S., et al. Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology 206 (2002) 408-423
30. Akbari O., Stock P., De Kruyff R.H., et al. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 15 (2003) 627-633
31. Herrick C.A., and Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 3 (2003) 405-412
32. Noverr M.C., and Huffnagle G.B. The emicroflora hypothesisf of allergic diseases. Clin Exp Allergy 35 (2005) 1511-1520
33. Yamanaka T., et al. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol 170 (2003) 816-822
34. Tlaskalova-Hogenova H., Stepankova R., Hudcovic T., et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93 (2004) 97-108
35. Strid J., and Strobel S. Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy 4 (2005) 531-541
36. Steinhoff M., Brzoska T., and Luger T.A. Keratinocytes in epidermal immune responses. Curr Opin Allergy Clin Immunol 1 (2001) 469-476
37. Pivarcsi A., and Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep 5 (2005) 284-290
38. Maurer D., and Stingl G. Langerhans cells. In: Lotze M.T., and Thomson A.W. (Eds). Dendritic cells (2001), Academic Press, London 35-50
39. Strid J., Hourihane J., Kimber I., et al. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 34 (2004) 2100-2109
40. Kondo H., Ichikawa Y., and Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 28 (1998) 769-779
41. Wang L.F., Lin J.Y., Hsieh K.H., et al. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J Immunol 156 (1996) 4077-4082
42. Herrick C.A., MacLeod H., Glusac E., et al. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest 105 (2000) 765-775
43. Mora J.R., Bono M.R., Manjunath N., et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424 (2003) 88-93
44. Johansson-Lindbom B.M., Svensson M.A., Wurbel B., et al. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 198 (2003) 963-969
45. + T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J Immunol 172 (2004) 857-863
46. Mora J.R., Cheng G., Picarella D., et al. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. JEM 201 (2005) 3003-3016
47. Yazdanbakhsh M., van den Biggelaar A., and Maizels R.M. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 22 (2001) 372-377
48. Yazdanbakhsh M., Kremsner P.G., and van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 296 (2002) 490-494
49. Sawczenko A., Sandhu B.K., Logan R.F., et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 357 (2001) 1093-1094
50. Sheikh A., Smeeth L., and Hubbard R. There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: lack of support for the hygiene hypothesis. J Allergy Clin Immunol 111 (2003) 131-135
51. Miraglia del Giudice Jr. M., de Luca M.G., et al. Probiotics and atopic dermatitis. A new strategy in atopic dermatitis. Digest Liver Dis 34 (2002) S68-S71
52. Fioramonti J., Theodorou V., and Bueno L. Probiotics: what are they? What are their effects on gut physiology?. Best Pract Res Clin Gastroenterol 17 (2003) 711-724
53. Miraglia del Giudice M., and De Luca M.G. The role of probiotics in the clinical management of food allergy and atopic dermatitis. J Clin Gastroenterol 38 6 Suppl (2004) S84-S85
54. Ogden N.S., and Bielory L. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Curr Opin Allergy Clin Immunol 5 (2005) 179-184
55. Majamaa H., and Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99 (1997) 179-185
56. Kunz B., Oranje A.P., Labreze L., et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195 (1997) 10-19
57. Isolauri E., Arvola T., Sutäs Y., et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 30 (2000) 1604-1610
58. Pessi T., Sutäs Y., Hurme M., et al. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30 (2000) 1804-1808
59. Rautava S., Kalliomäki M., and Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. JACI (2002) 109-121
60. Kalliomäki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079
61. Kalliomäki M., Salminen S., Poussa T., et al. Probiotics and prevention of atopic disease: r-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
62. Rosenfeldt V., Benfeldt E., Nielsen S.D., et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111 (2003) 389-395
63. Kirjavainen P.V., Salminen S.J., and Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 36 (2003) 223-227
64. Hattori K., Yamamoto A., Sasai M., et al. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi 52 (2003) 20-30
65. Pohjavuori E., Viljanen M., Korpela R., et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol 114 (2004) 131-136
66. Viljanen M., Kuitunen M., Haahtela T., et al. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 16 (2005) 65-71
67. Viljanen M., Savilahti E., Haahtela T., et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60 (2005) 494-500
68. Weston S., Halbert A., Richmond P., et al. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 90 (2005) 892-897
69. Szajewska H. Probiotics for treatment and prevention of allergic disease. What is the evidence? Atti Congresso Milanopediatria Workshop Alimentazione e Immunità Milano 11-13 Novembre 2004; 8-11.
70. Prescott S.L., and Tang M.L. The Australasian Society of Clinical Immunology and Allergy position statement: summary of allergy prevention in children. Med J Aust 182 (2005) 464-467
71. Cross M.L. Immunoregulation by probiotic lactobacilli: pro-Th1 signals and their relevance to human health. Clin Appl Immunol Rev 3 (2002) 115-125
72. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8 (2003) 223-246
73. Christensen H.R., Frokiaer H., and Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168 (2002) 171-178
74. Smits H.H., Engering A., van der Kleij D., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115 (2005) 1260-1267
75. Prescott S.L., Dunstan J.A., Hale J., et al. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy 35 (2005) 1557-1564
76. Salminen M.K., Rautelin H., Tynkkynen S., et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 38 (2004) 62-69
77. De Groote M.A., Frank D.N., Dowell E., et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 24 (2005) 278-280
78. Land M.H., Rouster-Stevens K., Woods C.R., et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115 (2005) 178-181
79. Salminen M.K., Rautelin H., Tynkkynen S., et al. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis 42 (2006) 35-44